An open label, multicenter, randomized, parallel controlled study to compare the efficacy and safety profile of chemo-radiotherapy with concomitant HMPL-002 use compared to standard chemo-radiotherapy for patients with inoperable stage IIIA/B non-small cell lung cancer
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 23 Feb 2009
At a glance
- Drugs Antineoplastics; HMPL 002
- Indications Cancer; Non-small cell lung cancer
- Focus Therapeutic Use
- Sponsors Chi-Med; Hutchison MediPharma
- 23 Feb 2009 New trial record.
- 08 Feb 2009 Interim results data have been reported in a Chi-Med media release.